Short Communication TLL1 Variants do not predict hepatocellular carcinoma development in hcv cirrhotic patients treated with direct‐acting antivirals E. Degasperi Corresponding Author E-mail address: elisabetta.degasperi@unimi.it CRC “A. M. e A. Migliavacca” Center for Liver Diseases, Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy Corresponding author Elisabetta Degasperi, MD CRC “A. M. e A.